Correction

Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review (vol 17, pg 605, 2011)

Journal

HUMAN REPRODUCTION UPDATE
Volume 22, Issue 4, Pages 532-533

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/humupd/dmw003

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

Article Obstetrics & Gynecology

Concerns about Data Integrity of 22 Randomized Controlled Trials in Women's Health

Yizhen Liu, Jim G. Thornton, Wentao Li, Madelon van Wely, Ben W. Mol

Summary: The analysis of 22 RCTs by Dr. Maged suggests potential data integrity issues, and it is recommended that journals investigate according to the guidelines of the Committee on Publication Ethics. The procedures demonstrated in this paper may help assess data integrity for future attempts to verify the authenticity of published RCTs.

AMERICAN JOURNAL OF PERINATOLOGY (2023)

Article Obstetrics & Gynecology

Alternatives to in vitro fertilization

Jennifer A. Wessel, Sarah Hunt, Madelon van Wely, Femke Mol, Rui Wang

Summary: This article reviews the concerns and considerations surrounding the overuse of in vitro fertilization (IVF), as well as the underappreciation of alternatives to IVF in clinical practice and research. It summarizes the current evidence on the effectiveness, safety, and cost-effectiveness of various alternatives to IVF, such as expectant management, intrauterine insemination, tubal flushing, in vitro maturation, and intravaginal culture. The article also discusses the trend of IVF use over the last decade and the roles of different alternatives to IVF in modern reproductive medicine.

FERTILITY AND STERILITY (2023)

Article Obstetrics & Gynecology

A core outcome set for future research in ectopic pregnancy: an international consensus development study

Krystle Y. Chong, Sarah Solangon, Kurt Barnhart, Pamela Causa-Andrieu, Perrine Capmas, George Condous, Liesl de Waard, James M. N. Duffy, Andrew W. Horne, Maria Memtsa, Femke Mol, Munira Oza, Romina Pesce, Annika Strandell, Madelon van Wely, Janneke van't Hooft, Lan N. Vuong, Jian Zhang, Davor Jurkovic, Ben W. Mol

Summary: This study developed a core outcome set for ectopic pregnancy (EP) to address methodological deficiencies in published randomized controlled trials and systematic reviews. The core outcome set consists of 6 outcomes, including treatment success, resolution time, the number of additional interventions, adverse events, mortality and severe morbidity, and treatment satisfaction.

FERTILITY AND STERILITY (2023)

Article Obstetrics & Gynecology

Long-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial

E. M. Bordewijk, T. Jannink, N. S. Weiss, T. de Vries, M. Nahuis, A. Hoek, M. Goddijn, B. W. Mol, M. van Wely, M-Ovin Study Grp

Summary: This study aimed to investigate the long-term outcomes of using gonadotrophins versus clomiphene citrate (CC) in women with normogonadotropic anovulation and clomiphene failure. The results showed that about four in five women were able to have a live birth after experiencing clomiphene failure, with no significant difference in pregnancy outcomes among the allocated groups.

HUMAN REPRODUCTION (2023)

Review Obstetrics & Gynecology

Methotrexate versus expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis

Sarah Annie Solangon, Madelon Van Wely, Norah Van Mello, Ben W. Mol, Jackie A. Ross, Davor Jurkovic

Summary: Ectopic pregnancy is a common health condition affecting 1 in 100 women. Methotrexate (MTX) and expectant management are both viable treatment options for women with mild symptoms and low hCG levels. A systematic review and meta-analysis of randomized controlled trials showed no statistically significant difference in treatment efficacy between MTX and expectant management, suggesting that initial expectant management may be preferred due to fewer side-effects.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2023)

Article Obstetrics & Gynecology

Childhood outcomes after induction of labor or expectant management for preterm prelabor rupture of membranes: a 10-year follow-up of the PPROMEXIL trials

Noor E. Simons, Annemijn A. de Ruigh, Janneke van't Hooft, Cornelieke S. H. Aarnoudse-Moens, Madelon van Wely, David P. van der Ham, Augustinus S. P. van Teeffelen, Tessa J. Roseboom, Ben W. Mol, Aleid G. Leemhuis, Eva Pajkrt

Summary: Management of late preterm prelabor rupture of membranes between 34+0 and 36+6 weeks' gestation shows similar risks between induction of labor and expectant management. However, children at 2 years of age show more neurodevelopmental delay with expectant management. Long-term outcomes in child development after 2 years are still unknown.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

Editorial Material Obstetrics & Gynecology

How to deal with time-to-pregnancy data?

Joanne Aalberts, Madelon van Wely

FERTILITY AND STERILITY (2023)

Article Obstetrics & Gynecology

The risk of hypogonadism after testicular sperm extraction in men with various types of azoospermia: a prospective cohort study

Jitske Eliveld, Ilias van der Bles, Madelon van Wely, Andreas Meissner, Alexandre T. Soufan, Annemieke C. Heijboer, Sjoerd Repping, Fulco van der Veen, Ans M. M. van Pelt

Summary: This study investigates the risk of hypogonadism in men with obstructive azoospermia, non-obstructive azoospermia (NOA) or Klinefelter syndrome after testicular sperm extraction (TESE). The results show that 36% of men with Klinefelter syndrome, 4% of men with obstructive azoospermia, and 3% of men with NOA required testosterone replacement therapy (TRT). Klinefelter syndrome is strongly associated with the need for TRT, while no association is found for obstructive azoospermia or NOA. Additionally, higher testosterone concentrations before TESE are linked to a lower chance of needing TRT.

REPRODUCTIVE BIOMEDICINE ONLINE (2023)

Article Obstetrics & Gynecology

Cost-effectiveness analysis of induction of labour at 41 weeks and expectant management until 42 weeks in low risk women (INDEX trial)

Aafke Bruinsma, Judit K. J. Keulen, Rik Van Eekelen, Madelon Van Wely, Joep C. Kortekaas, Jeroen Van Dillen, Joris A. M. Van de Post, Ben W. Mol, Esteriek de Miranda

Summary: This study assessed the cost-effectiveness of elective induction of labour (IOL) at 41 weeks compared to expectant management (EM) until 42 weeks for late-term pregnancies. The results showed that IOL has an 80% chance of being cost-effective for preventing adverse perinatal outcomes at a certain willingness-to-pay threshold. Subgroup analysis suggested that IOL may be cost-effective for nulliparous women, but unlikely to be cost-effective for multiparous women. The cost-effectiveness in other settings will depend on the baseline characteristics of the population and the organization and funding of the healthcare system.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X (2023)

Editorial Material Obstetrics & Gynecology

Series of overviews on miscarriage and recurrent miscarriage

Madelon van Wely

Summary: Miscarriage is a common occurrence that has a profound psychological impact on individuals and couples. This article provides an overview of sporadic and recurrent miscarriage, discussing their prevalence, psychological impact, genetics, the potential role of uterine natural killer cells, association with infections, and possible interventions.

FERTILITY AND STERILITY (2023)

Article Obstetrics & Gynecology

Role of infections in miscarriage

Elena B. Kostova, Jelmer R. Prins, Madelon van Wely

Summary: This manuscript discusses the association between infections and perinatal complications and the increased risk of miscarriage, as well as the availability of prevention or treatment strategies.

FERTILITY AND STERILITY (2023)

Article Obstetrics & Gynecology

The effect of dietary interventions on pain and quality of life in women diagnosed with endometriosis: a prospective study with control group

A. P. van Haaps, J. Wijbers, A. M. F. Schreurs, S. Vlek, J. Tuynman, B. De Bie, A. L. de Vogel, M. van Wely, V Mijatovic

Summary: The low FODMAP diet and endometriosis diet have a positive impact on reducing endometriosis-related pain and improving quality of life. However, further research and guidelines are needed to support these findings.

HUMAN REPRODUCTION (2023)

Letter Obstetrics & Gynecology

Artificial cycle frozen embryo transfer and obstetric adverse outcomes: association or causation?

T. R. Zaat, F. Mol, M. van Wely

HUMAN REPRODUCTION UPDATE (2023)

Editorial Material Obstetrics & Gynecology

Is it new, is it true and do we care-the role of prospective review registration

Madelon van Wely, Julie M. Hastings, Basil Tarlatzis, Arne Sunde

HUMAN REPRODUCTION UPDATE (2023)

Review Obstetrics & Gynecology

COVID-19 in pregnant women: a systematic review and meta-analysis on the risk and prevalence of pregnancy loss

Janneke A. C. van Baar, Elena B. Kostova, John Allotey, Shakila Thangaratinam, Javier R. Zamora, Mercedes Bonet, Caron Rahn Kim, Lynne M. Mofenson, Heinke Kunst, Asma Khalil, Elisabeth van Leeuwen, Julia Keijzer, Marije Strikwerda, Bethany Clark, Maxime Verschuuren, Arri Coomarasamy, Mariette Goddijn, Madelon van Wely

Summary: This systematic review aims to determine the prevalence of early pregnancy loss in women with SARS-Cov-2 infection and compare the risk to pregnant women without SARS-CoV-2 infection.

HUMAN REPRODUCTION UPDATE (2023)

No Data Available